Splenomegaly News and Research

RSS
Enlargement of the spleen is called splenomegaly and can occur as a result of many infections, tumors, and hereditary or acquired conditions of the blood leading to hemolysis. The enlarged spleen may also become overactive, devouring too many blood cells and producing other symptoms.
Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Hedgehog blockade promising in myeloid malignancies

Hedgehog blockade promising in myeloid malignancies

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Pocket-sized ultrasound device reduce need for further testing in inpatient and outpatient settings

Pocket-sized ultrasound device reduce need for further testing in inpatient and outpatient settings

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

New method that targets mosquito larvae and pupae may help control malaria

New method that targets mosquito larvae and pupae may help control malaria

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

Preclinical study shows PLX cells may help reverse symptoms associated with preeclampsia

Preclinical study shows PLX cells may help reverse symptoms associated with preeclampsia

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Results from Amgen’s Neulasta plus bevacizumab Phase 3 trial on colorectal cancer

Results from Amgen’s Neulasta plus bevacizumab Phase 3 trial on colorectal cancer

Brake for skin inflammation discovered

Brake for skin inflammation discovered

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Sanofi announces new data from SAR302503 Phase II trial on myelofibrosis

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis receives EC approval for Jakavi to treat myelofibrosis

Novartis receives EC approval for Jakavi to treat myelofibrosis